Skip to main content
Anthony Shields, MD, Oncology, Detroit, MI

AnthonyFShieldsMDPhD

Oncology Detroit, MI

Gastrointestinal Cancer

Associate Center Director, Karmanos Cancer Institute, Professor of Oncology, Wayne State University

Dr. Shields is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Shields' full profile

Already have an account?

  • Office

    4100 John R Street, HW04HO
    Karmanos Cancer Institute
    Detroit, MI 48201
    Phone+1 800-527-6266
    Fax+1 313-576-8767

Education & Training

  • University of Washington
    University of WashingtonFellowship, Hematology and Medical Oncology, 1981 - 1984
  • University of Washington
    University of WashingtonResidency, Internal Medicine, 1979 - 1981
  • Massachusetts Institute of Technology
    Massachusetts Institute of TechnologyPhD, Biology, 1973 - 1979
  • Harvard Medical School
    Harvard Medical SchoolClass of 1979

Certifications & Licensure

  • MI State Medical License
    MI State Medical License 1995 - 2027
  • WA State Medical License
    WA State Medical License 1980 - 2002
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Hematology
  • American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • Super Doctor SuperDoctors.com

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • Karmanos Cancer Institute Physicians Begin Prescribing New FDA-Approved Radiofrequency Electromagnetic Device to Treat Advanced Liver Cancer
    Karmanos Cancer Institute Physicians Begin Prescribing New FDA-Approved Radiofrequency Electromagnetic Device to Treat Advanced Liver CancerDecember 18th, 2024
  • Karmanos Cancer Institute Receives $630,000 CATCH-UP Grant to Recruit Minority and Rural Patients to Clinical Trials
    Karmanos Cancer Institute Receives $630,000 CATCH-UP Grant to Recruit Minority and Rural Patients to Clinical TrialsAugust 25th, 2020
  • OncLive® Presents State of the Science Summit™ on Gastrointestinal Malignancies
    OncLive® Presents State of the Science Summit™ on Gastrointestinal MalignanciesApril 23rd, 2019
  • Join now to see all

Grant Support

  • Imaging Cellular Stress And Treatment Response Using Positron Emission TomographyNational Cancer Institute2010–2012
  • Develpmental TherapeuticsNational Cancer Institute2005–2009
  • Labeled Thymidine -- Development As A PET Imaging AgentNational Cancer Institute2004–2008
  • Labeled Thymidine-Development As A PET Imaging AgentNational Cancer Institute2005–2006
  • Midcareer Investigator AwardNational Cancer Institute1999–2003
  • Labeled Thymidine--Development As A PET Imaging AgentNational Cancer Institute1997–2003
  • Developmental TherapeuticsNational Cancer Institute2001–2002
  • PET Imaging Of Drug Kinetics And PathwaysNational Cancer Institute1999–2002
  • Metabolic Measurement In Lymphoma Treated With ChemotherapyNational Cancer Institute1996–1997
  • Labeled Thymidine--Development As A PET Imaging AgentNational Cancer Institute1988–1994
  • Labeled Thymidine: Development As A PET Imaging AgentNational Cancer Institute1987–1993
  • Labeled Thymidine--Development As A PET Imaging AgentNational Cancer Institute1985–1987

Professional Memberships